-
Cernostics Announces Presentations Demonstrating New TissueCypher® Barrett’s Esophagus Assay
Cernostics, Inc. announced that findings from three scientific studies of its new TissueCypher® Barrett’s Esophagus Assay will be presented at the Digestive Disease Week (DDW) meeting in San Diego. DDW is the world’s largest conference on Gastro-intestinal Medicine. Cernostics’ TissueCypher® Barrett’s Esophagus Assay is the first clinical assay of its kind to predict the risk of developing esophageal cancer. Continue Reading…